# AZD0486 1L Therapy for Elderly or Unfit Participants With LBCL

> **NCT07215585** · PHASE3 · RECRUITING · sponsor: **AstraZeneca** · enrollment: 420 (estimated)

## Conditions studied

- Large B-cell Lymphoma

## Interventions

- **DRUG:** AZD0486
- **DRUG:** R-mini-CHOP

## Key facts

- **NCT ID:** NCT07215585
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-11-11
- **Primary completion:** 2030-06-10
- **Final completion:** 2033-07-28
- **Target enrollment:** 420 (ESTIMATED)
- **Last updated:** 2026-04-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07215585

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07215585, "AZD0486 1L Therapy for Elderly or Unfit Participants With LBCL". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07215585. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*